MedPath

Role of Asthisharinkhala Ghana Guggulu in the management of Osteoarthritis

Phase 2/3
Completed
Conditions
Osteoarthritis of knee, unspecified, patient with osteoarthritis,
Registration Number
CTRI/2018/05/014093
Lead Sponsor
OPD and IPD department of panchakarma
Brief Summary

Osteoarthritis (OA), which is also known as osteoarthrosis or degenerative joint disease (DJD), is a progressive disorderof the joints caused by gradual loss of cartilage and resulting in the development of bony spurs and cysts at the margins of the joints.The condition similar to Osteoarthritis has been described as *‘Sandhigatavata’* in *Ayurveda*, in which the vitiated *Vata* afflicts the joints and causes destruction of the cartilages and reduction in the synovial Fluid inside the joint capsule, leading to swelling which results into painful movement. Ayurvedic treatment of Osteoarthritis prevents further deterioration in the joints and rejuvenates damaged cartilages. Vata-alleviating treatments through specific herbs are suggested for lubrication and strengthening of joints.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Having sign and symptoms of Sandhivata (Osteoarthritis) as given below: 1.
  • Sandhi Shula (pain in the joint) 2.
  • Sandhi Shotha (Swelling in the joints) 3.
  • Sandhigraha (Morning Stiffness) 4.
  • Akunchana Prasaranayoh Vedana (Pain during Flexion and extension) 5.
  • Sparsha Asahyata (Tenderness) 6.
  • Sandhisphutana (Cracking of the joints) 7.
  • Crepitus in the joint.
  • Diagnostic Findings: 1.
  • Radiologic Osteophytes (If present) c.
  • Chronicity less than or equal to 5 years.
Exclusion Criteria
  • Patients below 30 and above 70 years of age.
  • Cases which require surgical intervention will be excluded.
  • Patient, suffering from any chronic debilitating disease like T.B., D.M., Rheumatoid Arthritis, Gout, Varicose veins, Asthma & other chronic problems etc.
  • and having other serious pathology.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Complete relief : 100%2 year
given scoring depending upon there severity.2 year
2. Marked improvement : 76% to 992 year
4. Mild improvement : 26 % to 50 %2 year
5. No improvement : 0% to 25 %2 year
To assess the effect of therapy all sign and symptoms were2 year
3. Moderate improvement : 51% to 75 %2 year
Secondary Outcome Measures
NameTimeMethod
Exacerbation in signs and synptoms30 DAYS

Trial Locations

Locations (1)

Rishikul Campus, Haridwar

🇮🇳

Hardwar, UTTARANCHAL, India

Rishikul Campus, Haridwar
🇮🇳Hardwar, UTTARANCHAL, India
Kshiteeja Choudhary
Principal investigator
9001214122
choudharykshiteeja@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.